"Or is it a case of Big Pharma not wanting to rush into a deal, because they are already making loads of money from what anti-cancer treatments they already have on the market that keeps the perpetual cancer-treatment wheel turning."
But interestingly both BMS's and Merck's big oncology drugs are having issues and not gaining as much income as they could.
CAVATAK makes them both more effective and safer (and much more commercially viable imho).
So while the market might been down on vla, their position is actually much better than when the sp was $1.35, as we are more advanced and have more info.
It has been suggested on HC that maybe Malcolm is playing hard ball, and wanting an offer around the $5 mark. But recent price weakness might mean that a takeover of $3 or less might work.
The best time for an offer to come is when they see the sp bottom, and that might have happened today.
If BMS or Merck got hold of vla for under $1b, I am sure that they will recoop that money in a very short time-frame, so it certainly makes sense. It also would make their product better than the oppositions.
cheers
ps. I bought back my shares sold at 82c today.
VLA Price at posting:
65.5¢ Sentiment: Buy Disclosure: Held
